EHR deep learning and sequencing identify two previously undiagnosed Noonan syndrome cases
Investigators applied a deep-learning model to diagnosis text in the electronic health records of 92,428 pediatric patients. It flagged 171 patients above a prespecified Noonan syndrome risk threshold for chart review; genetic sequencing and specialist assessment identified two previously undiagnosed Noonan syndrome cases among evaluated patients, in addition to three patients diagnosed during the study period. The confirmed cases had pathogenic variants in Noonan-associated genes, including PTPN11 and LZTR1. This supplies real-world evidence that EHR-based model screening can surface rare-disease cases for clinical genetic evaluation.
Technology: Deep convolutional neural network trained on structured electronic-health-record diagnosis text to estimate Noonan syndrome risk
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: retrospective or benchmark
- Tested: The confirmed cases had pathogenic variants in Noonan-associated genes, including PTPN11 and LZTR1.
- Still unknown: This was a real-world retrospective screening evaluation at one pediatric biobank, not a prospective screening trial. Sequencing identified two cases among 83 patients evaluated, and the overall precision among the 171 high-risk patients was 2.92%; the model therefore required substantial chart review and genetic confirmation. Retrospective risk trajectories suggest possible earlier recognition but do not establish earlier care or improved outcomes.
- AI role: The previously developed deep-learning model scored 92,428 patient records and ranked 171 individuals above a prespecified risk threshold. The study team reviewed high-risk records, then used clinical genetic assessment and sequencing to evaluate patients without a prior diagnosis; these follow-up tests confirmed two previously undiagnosed cases. Model risk trajectories were also reconstructed from cumulative EHR diagnoses to assess whether the signal appeared before final diagnosis.
Evidence sources: https://www.nature.com/articles/s41525-025-00512-5
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: at percentile 80 of works of the same type, year and subfield (OpenAlex work metrics, 5 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.